Pulmonary Hypertension: Assessment of Cell Therapy
NCT00469027
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension, Pulmonary
Interventions
BIOLOGICAL:
eNOS transfected EPCs will be delivered via a PA line
Sponsor
Northern Therapeutics
Collaborators
[object Object]
[object Object]